References

Here are selected research papers on the study of misfolded proteins (or prion particles) and how they affect brain diseases.

1.

Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis

2.

Modeling Parkinson’s Disease with the Alpha Synuclein Protein

3.

Lewy body dementia: The caregiver experience of clinical care

4.

a-Syn in the pathophysiology of AD

5.

Comorbid neuropathological diagnoses in early versus late-onset Alzheimer’s disease

6.

α-Synuclein in cerebrospinal fluid of Alzheimer’s Disease and Mild Cognitive Impairment.

7.

Treatment of Dementia with Lewy Bodies

8.

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium

9.

The costs of dementia subtypes to California Medicare fee-for-service, 2015

10.

Discriminating α-Synuclein strains in Parkinson’s disease and multiple system atrophy (Shahnawaz et al 2020)

11.

Diagnostic Value of the CSF α-Synuclein Real-Time Quaking-Induced Conversion Assay at the Prodromal MCI Stage of Dementia With Lewy Bodies

Do good by doing well, do well by doing good.”

– Russ Lebovitz, CEO & CoFounder

A pioneer in the science of detecting mis-folded proteins, Amprion advances the diagnosis of brain disorders. Our SYNTap™️ Biomarker Test aids physicians in diagnosing Parkinson’s, Lewy Body Dementia, and Alzheimer’s with Lewy Body variant. We plan to launch more biomarker tests in the future.

Company

Support

Clinical Lab

This website is intended for the informational purposes of healthcare professionals.
AMPRION & SYNTap are registered trademarks of Amprion Inc. © 2007-2023 Amprion Inc. All rights reserved.